WuXi Biologics increases issued share capital by 3m shares

WuXi Biologics (Cayman) Inc. reported an increase of 3,000,000 ordinary shares in its issued share capital as of November 14, 2025. This change brings the total number of issued shares to 4,102,658,633 from an opening balance of 4,099,658,633 on November 13, 2025. The new shares represent approximately 0.07318% of the company's existing issued shares prior to the event.

The increase stems from two primary activities: the issue of new shares or transfer of treasury shares related to share awards or options granted to a director under a share scheme, and the exercise of share options under the Pre-IPO Share Option Scheme, originally adopted on January 5, 2016, and amended on August 10, 2016. These new ordinary shares were issued at a price of HK$1.29 per share.

The company confirmed that all necessary regulatory and legal requirements have been met, including authorization by the board of directors, compliance with listing rules, and the filing of required documents with the Registrar of Companies. All shares issued are identical, carrying the same rights and entitlements. There were no changes in the number of treasury shares, which remained at zero.